New drug combo targets tough prostate cancer in understudied groups
Disease control
Terminated
This study was designed to test a combination of two drugs (niraparib and abiraterone plus prednisone) in Hispanic/Latino and Black patients with metastatic hormone-sensitive prostate cancer that has certain gene mutations. The goal was to see if the treatment could lower PSA lev…
Phase: PHASE2 • Sponsor: Qian Qin • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC